These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 1295397)

  • 1. Interview with Robert Schwartz. What is going to happen tomorrow in the field exploring the relationship between viruses and autoimmunity?. Interview by P. Youinou.
    Schwartz R
    Ann Med Interne (Paris); 1992; 143(6):419-20. PubMed ID: 1295397
    [No Abstract]   [Full Text] [Related]  

  • 2. Interview with Joachim Robert Kalden. What is going to happen tomorrow as far as DNA and anti-DNA antibodies are concerned?. Interview by P. Youinou.
    Kalden JR
    Ann Med Interne (Paris); 1993; 144(7):463-4. PubMed ID: 8141512
    [No Abstract]   [Full Text] [Related]  

  • 3. [An interview with Jean-Michel Dayer: what is going to happen tomorrow in the field of cytokines?. Interview by P Youinou].
    Dayer JM
    Ann Med Interne (Paris); 1992; 143(7):445-7. PubMed ID: 1300865
    [No Abstract]   [Full Text] [Related]  

  • 4. Interview with Graham Hughes. What is going to happen tomorrow in the field of anti-phospholipid antibodies?. Interview by P. Youinou.
    Hughes G
    Ann Med Interne (Paris); 1992; 143(6):417-8. PubMed ID: 1295396
    [No Abstract]   [Full Text] [Related]  

  • 5. [An interview with Sylviane Muller by P Youinou. What is going to happen tomorrow in the field of synthetic peptides of autoantigens?].
    Muller S
    Ann Med Interne (Paris); 1993; 144(5):319-22. PubMed ID: 8291840
    [No Abstract]   [Full Text] [Related]  

  • 6. Interview with Ivan M. Roitt. What is going to happen tomorrow as far as glycosylation of IgG is concerned?. Interview by P. Youinou.
    Roitt IM
    Ann Med Interne (Paris); 1993; 144(6):389-91. PubMed ID: 8122821
    [No Abstract]   [Full Text] [Related]  

  • 7. [Interview with Dominique Charron. What is going to happen tomorrow in the understanding of the functioning of HLA molecules?. Interview by P. Youinou].
    Charron D
    Ann Med Interne (Paris); 1995; 146(1):25-8. PubMed ID: 7741390
    [No Abstract]   [Full Text] [Related]  

  • 8. Interview with Joaquim Coll. What is going to happen tomorrow as far as secondary Sjögren's syndrome is concerned?. Interview by P. Youinou.
    Coll J
    Ann Med Interne (Paris); 1993; 144(4):257-9. PubMed ID: 8368718
    [No Abstract]   [Full Text] [Related]  

  • 9. [An interview with Alan Ebringer. What is going to happen tomorrow concerning HLA-B27 and ankylosing spondylathritis?. Interview by P. Youinou].
    Ebringer A
    Ann Med Interne (Paris); 1994; 145(4):238-40. PubMed ID: 8092648
    [No Abstract]   [Full Text] [Related]  

  • 10. [Interview with Pierre Godeau, President of the Société Nationale Française de Médecine Interne. What is going to happen tomorrow in internal medicine?. Interview by Pierre Youinou].
    Godeau P
    Ann Med Interne (Paris); 1994; 145(1):3-6. PubMed ID: 8192278
    [No Abstract]   [Full Text] [Related]  

  • 11. Interview with Haralampos M. Moutsopoulos. What's going to happen as far as the natural history of Sjögren's syndrome is concerned?. Interview by Pierre Youinou.
    Moutsopoulos HM
    Ann Med Interne (Paris); 1994; 145(3):175-6. PubMed ID: 8092631
    [No Abstract]   [Full Text] [Related]  

  • 12. [Interview with Jean-François Borel. What is going to happen tomorrow in the field of cyclosporine?].
    Borel JF
    Ann Med Interne (Paris); 1995; 146(4):251-3. PubMed ID: 7653946
    [No Abstract]   [Full Text] [Related]  

  • 13. [An interview with Loïc Guillevin. What is going to happen tomorrow in the field of vasculitis?].
    Guillevin L
    Ann Med Interne (Paris); 1994; 145(8):514-6. PubMed ID: 7710176
    [No Abstract]   [Full Text] [Related]  

  • 14. [Interview with Jean-Marie Seigneurin. What is going to happen tomorrow in the field of Epstein-Barr virus?].
    Seigneurin JM
    Ann Med Interne (Paris); 1994; 145(2):107-9. PubMed ID: 8024174
    [No Abstract]   [Full Text] [Related]  

  • 15. [Interview with Gilbert Fournié. What is going to happen tomorrow in the field of physiopathology of systemic lupus erythematosus?].
    Fournié G
    Ann Med Interne (Paris); 1996; 147(5):320-5. PubMed ID: 9033733
    [No Abstract]   [Full Text] [Related]  

  • 16. Interview with Pier-Luigi Meroni. What is going to happen tomorrow in the field of anti-endothelial cell autoantibodies related to vasculitis?
    Meroni PL
    Ann Med Interne (Paris); 1994; 145(7):467-8. PubMed ID: 7864514
    [No Abstract]   [Full Text] [Related]  

  • 17. [Interview with Moncef Zouali: What is going to happen tomorrow in the field of lupus anti-DNA antibodies?].
    Zouali M
    Ann Med Interne (Paris); 1995; 146(5):316-8. PubMed ID: 8526316
    [No Abstract]   [Full Text] [Related]  

  • 18. Interview with Frank Hay. What is going to happen tomorrow as far as rheumatoid factor is concerned?
    Hay F
    Ann Med Interne (Paris); 1995; 146(7):479-80. PubMed ID: 8787288
    [No Abstract]   [Full Text] [Related]  

  • 19. Interview with Steven A. Krilis. What is going to happen tomorrow for beta 2-glycoprotein I?
    Krilis SA
    Ann Med Interne (Paris); 1995; 146(3):212-4. PubMed ID: 7544557
    [No Abstract]   [Full Text] [Related]  

  • 20. Interview with Norman Talal. What is going to happen tomorrow as far as Sjögren's syndrome is concerned?
    Talal N
    Ann Med Interne (Paris); 1993; 144(1):21-2. PubMed ID: 8503601
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.